Search results
8 sie 2023 · Optimal treatment for recurrent cervical cancer remains an area of unmet need, necessitating further exploration of rational and innovative treatment approaches, including cell and immune-based therapies.
Management includes fertility sparing treatment, early and locally advanced cervical cancer, invasive cervical cancer diagnosed on a simple hysterectomy specimen, cervical cancer in pregnancy, rare tumors, recurrent and metastatic diseases.
4 mar 2022 · The updated recommendation (plus the other 2016 options) for January 2022 is: clinicians may offer upfront pembrolizumab and chemotherapy with or without bevacizumab to eligible patients with persistent, recurrent, or metastatic cervical carcinoma (± individualized radiation therapy and/or palliative care) in enhanced and maximal settings ...
7 sie 2024 · Depending on stage, histology, and patient factors, the standard management of cervical cancer is a combination of treatment approaches, including (fertility- or non-fertility-sparing) surgery, radiotherapy, platinum-based chemotherapy, and novel systemic therapies such as bevacizumab, immune checkpoint inhibitors, and antibody-drug conjugates.
management of adult patients with cervical cancer being treated in the United Kingdom. Grades of recommendations Recommendations are graded as per the Royal College of Obstetricians and Gynaecologists document.
systemic therapy options for recurrent and metastatic cervical cancer were amended upon panel review of new survival data and the FDA’s approval of bevacizumab for treating late-stage cervical cancer.
Treatment options depend on the type of cervical cancer, its stage, whether it is newly-diagnosed or recurrent (returned) and if the woman wants to preserve fertility. Surgery Early-stage (confined to the cervix) cervical cancer is usually treated with surgery. Surgical options include: •Cone biopsy. In this procedure, very small cervical cancers
